Form 8-K - Current report:
SEC Accession No. 0001079973-25-000177
Filing Date
2025-01-31
Accepted
2025-01-31 16:34:43
Documents
15
Period of Report
2025-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 29246
2 FORM OF PROMISSORY NOTE ex4x1.htm EX-4.1 33033
  Complete submission text file 0001079973-25-000177.txt   289007

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE scpx-20250130.xsd EX-101.SCH 3549
4 XBRL DEFINITION FILE scpx-20250130_def.xml EX-101.DEF 26579
5 XBRL LABEL FILE scpx-20250130_lab.xml EX-101.LAB 36527
6 XBRL PRESENTATION FILE scpx-20250130_pre.xml EX-101.PRE 25203
17 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25578843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)